Due to overvaluation, the following stocks are likely to decline more before they start to bottom out. Apple (AAPL): Lack of stimulus and inflation will likely lead to lower profits this year. Microsoft (MSFT): Declining quarterly net income and the announcement to almost double employee salaries might lead to a disappointing earnings report. Prologis (PLD):
0 Comments
What Are NPV and IRR? Net present value (NPV) is the difference between the present value of cash inflows and the present value of cash outflows over a period of time. By contrast, the internal rate of return (IRR) is a calculation used to estimate the profitability of potential investments. Both of these measurements are primarily used
0 Comments
Although the market turmoil may have investors scrambling for cover, these retirement stocks can likely withstand the heat. Brookfield Infrastructure (BIPC): One of the largest owners and operators of critical global infrastructure networks, Brookfield presents unbeatable relevance. Duke Energy (DUK): A classic name among retirement stocks, Duke Energy’s pertinent business and compelling coverage map make
0 Comments
Nio’s (NIO) Singapore listing isn’t going to do investors any favors. Recent earnings results show weakness. Nio is a surprisingly minor player in its biggest market. I’ve long been a proponent of Chinese EV manufacturer Nio (NYSE:NIO) and its stock. However, a host of recent factors is causing me to change that opinion. Nio’s current
0 Comments
In the current market evironment, investors could find solid ground with this dividend stocks to buy. Merck (MRK): Robust results across its core portfolio, with its oncology portfolio expected to fire on all cylinders. Chevron (CVX): Cash flow generating machine, which will benefit immensely from rising oil prices. Clorox (CLX): Attractive income stock, which has seen
0 Comments
Though the broader market volatility has presented intriguing, discounted opportunities, some ideas are simply stocks to avoid. Novavax (NVAX) — A huge winner during the height of the coronavirus pandemic, the resultant societal fatigue makes NVAX too risky for conservative investors. Teladoc Health (TDOC) — While TDOC has given up all of its post-pandemic gains
0 Comments